Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03810105
Title A Study of Olaparib and Durvalumab in Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center

prostate cancer


Durvalumab + Olaparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST